Inflammatory mediator pathways in macrophages

Inflammatory mediator pathways in macrophages represent a complex network of signaling cascades that govern the cellular response to pathogens and tissue injury (Nature Reviews Immunology, 2017). Macrophages utilize pattern recognition receptors, such as Toll-like receptors, to detect environmental cues and initiate downstream signaling through the NF-kappaB, MAPK, and JAK-STAT pathways (Cell, 2011). These pathways culminate in the transcriptional activation of genes encoding pro-inflammatory cytokines, including TNF-alpha, IL-1 beta, and IL-6 (Journal of Clinical Investigation, 2015). While essential for host defense, the chronic or aberrant activation of these pathways is a central driver in the pathogenesis of autoimmune diseases like rheumatoid arthritis and chronic inflammatory conditions such as atherosclerosis (Nature, 2017). Pharmacological intervention typically targets specific nodes within these pathways, such as kinases or the cytokines themselves, to alleviate systemic inflammation (Lancet, 2016). However, the broad suppression of these pathways poses significant therapeutic challenges, primarily the increased risk of serious opportunistic infections due to impaired immune surveillance (Clinical Infectious Diseases, 2018).

Other names

Macrophage inflammatory signalingPro-inflammatory pathways in macrophagesMacrophage activation pathwaysMacrophage inflammatory response

Modulation of macrophage-mediated inflammation through the inhibition of intracellular signaling cascades (e.g., JAK/STAT, NF-kappaB) or the neutralization of secreted pro-inflammatory cytokines (e.g., TNF-alpha, IL-1 beta).